Ovarian cancer is the leading cause of death from gynecological cancer.
INTRODUCTION
Ovarian cancer is the leading cause of death from gyne colo gical cancer. Ovarian cancer is fifth leading cause of death among the women World over. It is third leading cancer among Indian women after cervical and breast cancer. The age adjusted incidence rates of ovarian cancer vary between 5.4 and 8 per 100,000 population in different parts of the country. 1 The overall 5year survival rate is approximately 45%, due to late stage at diagnosis of the disease. India with its 1 billion population has a huge burden of the disease. Most of the ovarian cancers are initially operated by general gynecologists since trained gynecologist are very few in our country. Advance stage of disease at the time of diagnosis, inappropriate management, and poor compliance to therapy all together are responsible for the dismal survival rates.
MATERIALS AND METHODS
Laparotomy with midline or extended midline incision was done in all cases. Peritoneal fluid was collected in all cases for cytological study. Surgical staging was done. Surgical approach was indivi dualized. Appropriate surgery, ranging from unilateral salpingooophorectomy to total abdominal hysterectomy and bilateral salpingooophorectomy with omentectomy was done in each case based on age, parity, and staging of the tumor.
The pelvic and paraaortic lymphnodes were evaluated and enlarged ones were resected.
The other operative findings recorded were tumor size, gross appearance, cut surface, presence of ascites and sites of extraovarian involvement.
Histological study was done in our pathology department. International Federation of Gynecology and Obstetrics staging of ovarian cancer was done. Classification of all histological diag nosis was based on World Health Organi zation histo logical classification of ovarian tumors. Postoperative chemo therapy was given on the basis of staging and tumor type. All cases were followedup.
RESULTS
Of the 50 cases of ovarian tumors diagnosed and operated, 22 (44%) were malignant. Most of them (77.3%) occurred in the reproductive age group (Table 1) , while 13.6% occurred in post menopausal women. Nulliparity was associated with 27.3% of malignant tumors.
The mean age of presentation in malignant tumors was 41 years.
Duration of symptoms was 1 month or less in majority (54.6%) of malignant tumors.
The malignant tumors presented with abdominal dis ten tion (73%) ( Table 2) , abdominal pain (52%), constitutional (21.5%) and gastrointestinal symptoms (10.5%). Ascites were found in 40.9% of malignant tumors and of them 88.9% were in stages III and IV. At the time of diagnosis, 68.2% malignant tumors were in stages III and IV.
Bilaterality was found in 27.3% of tumors. The most common histotype was serous (Table 3 ) cystadeno carcinoma (45.5%), followed by mucinous cys tadenocarcinoma (27.3%). 2 The diameter was 12.6 cm. Mucinous cystadenocarcinoma had the largest mean diameter (23 cm).
The lesions were cystic in 18.2%, solid in 22.7% and variegated in 59.1% cases. Serous cystadenocarcinoma consti tuted for majority of cystic lesions. Krigman and Padubidri also found serous tumors to be most common (46% and 50% respectively) followed by mucinous tumors (36% and 15%, respectively).
Okugawa et al 13 found mean age of malignant tumor to be 51.9 years. The mean age in present study was 1 decade younger. Okugawa et al 13 also found the mean diameter of malig nant tumor to be 13.6 ± 6.5 cm. Krigman et al found mucinous tumors to be the largest with diameters often more than 30 cm. Padubidri et al 12 described serous cystadenocarcinoma to be the most common cystic ovarian malignancy. Bhatia et al 14 found solid, nodular and irregular shapes commonly associated with malignant tumors. They also found malignant lesions often to be multilocular with thick walls, septae and solid areas. 
SUMMARy AND CONCLUSION
Out of 50 cases of ovarian tumors, 22 cases (44%) cases were malignant. The malignant tumors were commonly found in the reproductive age group (77.3%). The mean age of presen tation was 41 years. The commonest modes of presentation were abdominal distention (73%) and abdo minal pain (52%). The most common histotype was serous cystadenocarcinoma (45.5%). At the time of diagnosis, 68.2% of malignant tumors were in stages III and IV.
Benign ovarian neoplasms are more common than malignant ones. The most common benign ovarian neoplasm is serous cystadenoma and the commonest malignant neo plasm is serous cystadenocarcinoma. The prevalence of malig nant ovarian neoplasms increases with increasing age.
Early diagnosis and treatment can reduce the morbidity and mortality if the clinician keeps this in mind.
